Home

cső tempó tehetetlenség trek1 1 Zajos Megtorlás Nem hatékony

The neuronal background K2P channels: focus on TREK1 | Nature Reviews  Neuroscience
The neuronal background K2P channels: focus on TREK1 | Nature Reviews Neuroscience

Frontiers | Role of TREK-1 in Health and Disease, Focus on the Central  Nervous System
Frontiers | Role of TREK-1 in Health and Disease, Focus on the Central Nervous System

1.1 | Trek Bikes
1.1 | Trek Bikes

TREK-1 and Best1 Channels Mediate Fast and Slow Glutamate Release in  Astrocytes upon GPCR Activation: Cell
TREK-1 and Best1 Channels Mediate Fast and Slow Glutamate Release in Astrocytes upon GPCR Activation: Cell

K2P2.1 (TREK-1)–activator complexes reveal a cryptic selectivity filter  binding site | Nature
K2P2.1 (TREK-1)–activator complexes reveal a cryptic selectivity filter binding site | Nature

Protein and Chemical Determinants of BL-1249 Action and Selectivity for K2P  Channels | ACS Chemical Neuroscience
Protein and Chemical Determinants of BL-1249 Action and Selectivity for K2P Channels | ACS Chemical Neuroscience

Sodium permeable and “hypersensitive” TREK‐1 channels cause ventricular  tachycardia | EMBO Molecular Medicine
Sodium permeable and “hypersensitive” TREK‐1 channels cause ventricular tachycardia | EMBO Molecular Medicine

Trek 1.1 review | Cycling Weekly
Trek 1.1 review | Cycling Weekly

1.1 | Trek Bikes
1.1 | Trek Bikes

Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related  K+ Channel 1). A Novel Therapeutic Target? | Journal of Medicinal Chemistry
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K+ Channel 1). A Novel Therapeutic Target? | Journal of Medicinal Chemistry

1.1 | Trek Bikes
1.1 | Trek Bikes

TREK1 channel activation as a new analgesic strategy devoid of opioid  adverse effects - Busserolles - 2020 - British Journal of Pharmacology -  Wiley Online Library
TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects - Busserolles - 2020 - British Journal of Pharmacology - Wiley Online Library

Spadin, a Sortilin-derived peptide: a new concept in the antidepressant  drug design | OCL - Oilseeds and fats, Crops and Lipids
Spadin, a Sortilin-derived peptide: a new concept in the antidepressant drug design | OCL - Oilseeds and fats, Crops and Lipids

TREK1.1
TREK1.1

The 2-Pore Domain Potassium Channel TREK-1 Regulates Stretch-Induced  Detachment of Alveolar Epithelial Cells | PLOS ONE
The 2-Pore Domain Potassium Channel TREK-1 Regulates Stretch-Induced Detachment of Alveolar Epithelial Cells | PLOS ONE

JCI - The two-pore domain potassium channel TREK-1 mediates cardiac  fibrosis and diastolic dysfunction
JCI - The two-pore domain potassium channel TREK-1 mediates cardiac fibrosis and diastolic dysfunction

IJMS | Free Full-Text | The Knockdown of TREK-1 in Hippocampal Neurons  Attenuate Lipopolysaccharide-Induced Depressive-Like Behavior in Mice
IJMS | Free Full-Text | The Knockdown of TREK-1 in Hippocampal Neurons Attenuate Lipopolysaccharide-Induced Depressive-Like Behavior in Mice

POPDC1 scaffolds a complex of adenylyl cyclase 9 and the potassium channel  TREK‐1 in heart | EMBO reports
POPDC1 scaffolds a complex of adenylyl cyclase 9 and the potassium channel TREK‐1 in heart | EMBO reports

Discovery of an Inhibitor for the TREK-1 Channel Targeting an Intermediate  Transition State of Channel Gating | Journal of Medicinal Chemistry
Discovery of an Inhibitor for the TREK-1 Channel Targeting an Intermediate Transition State of Channel Gating | Journal of Medicinal Chemistry

Anti-KCNK2 (TREK-1) Antibody | KO Validated | APC-047 | Alomone Labs
Anti-KCNK2 (TREK-1) Antibody | KO Validated | APC-047 | Alomone Labs